IL6 and campylobacteriosis: Strikingly, the potent campylobacteriosis ameliorating effects upon carvacrol treatment could also be assessed systemically given that serum concentrations of TNF, IFN-γ, MCP-1 and IL-6 were lower in carvacrol as compared to PLC treated C. jejuni infected mice.